Vertex Pharmaceuticals (VRTX) Convertible Debt (2010 - 2013)
Vertex Pharmaceuticals' quarterly Convertible Debt came in at $400.0 million in Q1 2013, little changed year-on-year from $400.0 million in Q1 2012, and little changed quarter-over-quarter from $400.0 million in Q4 2012.
Vertex Pharmaceuticals has reported Convertible Debt for 4 years, with the latest figure at $400.0 million in Q1 2013.
- For the quarter ending Q1 2013, Convertible Debt changed 0.0% year-over-year to $400.0 million; the trailing twelve-month figure through Mar 2013 stood at $400.0 million (changed 0.0% YoY), and the FY2012 full-year result was $400.0 million, changed 0.0% from the prior year.
- Convertible Debt for Q1 2013 stood at $400.0 million, roughly flat from $400.0 million in the prior quarter.
- The five-year high for Convertible Debt was $400.0 million in Q3 2010, with the low at $32.1 million in Q1 2010.
- Average Convertible Debt over 4 years is $366.6 million, with a median of $400.0 million recorded in 2010.
- Peak annual rise in Convertible Debt reached 1146.11% in 2011, while the deepest fall reached 0.0% in 2011.
- Tracing VRTX's Convertible Debt over 4 years: stood at $400.0 million in 2010, then changed by 0.0% to $400.0 million in 2011, then changed by 0.0% to $400.0 million in 2012, then changed by 0.0% to $400.0 million in 2013.
- The last three Convertible Debt figures came in at $400.0 million (Q1 2013), $400.0 million (Q4 2012), and $400.0 million (Q3 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 400.00 Mn |
| Dec 31, 2012 | 400.00 Mn |
| Sep 30, 2012 | 400.00 Mn |
| Jun 30, 2012 | 400.00 Mn |
| Mar 31, 2012 | 400.00 Mn |
| Dec 31, 2011 | 400.00 Mn |
| Sep 30, 2011 | 400.00 Mn |
| Mar 31, 2011 | 400.00 Mn |
| Dec 31, 2010 | 400.00 Mn |
| Sep 30, 2010 | 400.00 Mn |
| Mar 31, 2010 | 32.10 Mn |